These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 24299784

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
    Chen HM, Yan XJ, Wang F, Lin J, Xu WF.
    Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W, Jin K, Lan H, Han N, Cao F, Teng L.
    Hepatogastroenterology; 2012 Jun; 59(120):2543-7. PubMed ID: 22534543
    [Abstract] [Full Text] [Related]

  • 5. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z, Wu M, Miao J, Duan H, Zhang S, Chen M, Sun L, Wang Y, Zhang X, Zhu X, Zhang L.
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [Abstract] [Full Text] [Related]

  • 6. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A, Aigner A, Bakowsky U.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
    Komi Y, Ohno O, Suzuki Y, Shimamura M, Shimokado K, Umezawa K, Kojima S.
    Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
    Thapa D, Lee JS, Heo SW, Lee YR, Kang KW, Kwak MK, Choi HG, Kim JA.
    Eur J Pharmacol; 2011 Jan 10; 650(1):64-71. PubMed ID: 20950604
    [Abstract] [Full Text] [Related]

  • 13. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
    Xu HY, Pan YM, Chen ZW, Lin Y, Wang LH, Chen YH, Jie TT, Lu YY, Liu JC.
    J Ethnopharmacol; 2013 Apr 19; 146(3):724-33. PubMed ID: 23434607
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.
    J Ethnopharmacol; 2012 Jun 01; 141(2):721-7. PubMed ID: 21911050
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma.
    Zheng L, He X, Ma W, Dai B, Zhan Y, Zhang Y.
    Biomed Pharmacother; 2012 Oct 01; 66(7):499-505. PubMed ID: 22854322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis.
    Ilić M, Ilaš J, Dunkel P, Mátyus P, Boháč A, Liekens S, Kikelj D.
    Eur J Med Chem; 2012 Dec 01; 58():160-70. PubMed ID: 23124213
    [Abstract] [Full Text] [Related]

  • 20. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J, Chen Y, Wei L, Hong Z, Sferra TJ, Peng J.
    Int J Oncol; 2013 Nov 01; 43(5):1666-74. PubMed ID: 24042330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.